Cidara Therapeutics's total assets for Q3 2025 were $518.65M, a decrease of -2.93% from the previous quarter. CDTX total liabilities were $96.26M for the fiscal quarter, a 190.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.